Virtu Financial’s Pulse Biosciences PLSE Stock Holding History

Virtu Financial’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,606	Closed	-$157K	–	2379
2018 Q1	$157K	Buy	+11,606	New	+$220K	0.01%	1448

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCP

Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Virtu Financial's PLSE Position: Q2 2018 in Review

Virtu Financial sold out of Pulse Biosciences (PLSE) in Q2 2018, closing a stake of 11,606 shares — an estimated $157K sold.

Virtu Financial first reported a position in PLSE in Q1 2018 and held it in 1 quarter. The position peaked at $157K in Q1 2018. 43 funds tracked by Wall St. Rank hold PLSE as of Q2 2018.

Virtu Financial reported no remaining Pulse Biosciences position as of Q2 2018 after selling out during the quarter.
Virtu Financial sold 11,606 Pulse Biosciences shares in Q2 2018, an estimated $157K.
Virtu Financial first reported a position in Pulse Biosciences in Q1 2018 and held it in 1 quarter.
Virtu Financial's Pulse Biosciences position peaked at $157K in Q1 2018.
43 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2018.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.